ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S
July 04, 2018NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 million extension of the Series B round. Together with an earlier CHF 20 million series B fin -
Which is to dominate the future heart failure drug market?(2)
October 27, 2017Sales of Entresto® rising steadily upon the Class I recommendation by the European and American heart failure guideline... -
Which is to dominate the future heart failure drug market?(1)
October 26, 2017An incident happened to the representative heart disease products with TCM characteristics several days ago, which attracted broad attention of the industry.
Pharma Sources Insight January 2025
